.Brian D Nicholson OxPrimaryCareSci discusses why we need early detection studies in primary care, the most common route for cancer diagnosis, so that the patients at highest risk can be prioritised for further investigation #oxcode23

If you've decided now is the time to get serious about your startup, we don't want you to miss out on the chance to participate in the W24 batch. So we're opening up at least 10 more spots for companies that apply now via a special application process. ycombinator.com/blog/new-year-…

High gradient but big AVA? The gradient wins! A really interesting paper: Prognosis of Discordant High-Gradient Aortic Stenosis: Trust the Gradient sciencedirect.com/science/articl…

Cool new paper in Cell that ties together two fundamentals of cancer biology: cancer cells have high levels of lactate (due to the Warburg effect), and almost always find a way to inactivate the cell's best tumour suppressor, p53 Zong et al. found that lactate, from the

Exactly 1,100 days after suffering a cardiac arrest on the pitch at Euro 2020, Christian Eriksen scores for Denmark at Euro 2024! 🇩🇰 What a story 👏

NEW content online! Exploiting temporal aspects of cancer immunotherapy dlvr.it/T8Q0kd

Congrats to Rice's 13th Rhodes Scholar, Jae Kim 👐🦉👐 Truly well-deserved.

What surviving the great SF Tsunami taught me about B2B sales 🧵

Scavenger receptor CD163 multimerises to allow uptake of diverse ligands biorxiv.org/cgi/content/sh… #biorxiv_biochem

Really fascinating read here- three of the same CD163 monomers working asymmetrically to allow the uptake of diverse ligands. Don't think I've seen this kind of binding before, nature cooks up some interesting mechanisms sometimes!

New #JITC article: Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers bit.ly/3Wclz3f

I’m excited to introduce Collate and announce our $30M seed round. We’re using AI to help solve one of the biggest problems for life sciences companies — the never-ending cycle of document creation and maintenance you need to do to stay compliant. While running my first

Today we report in Nature Medicine the development of a base editing strategy for prion disease, currently a fatal and rapidly progressing neurogenerative condition with no effective treatment. @PrionAlliance DevermanLab (1/13) drive.google.com/file/d/1DVpKrz…

Check out what we're working on at Olio Labs! 70% of patients taking GLP-1's (like Ozempic) are women, but they experience >2x side effect rates than men. What is driving this difference? We combine human EMR data, mouse & rat behavior, and scRNAseq to figure it out:

Reminds me of one of the worst cases of scientific fraud ever: >cardiologist fakes data showing better outcomes for patients who were given beta blockers before surgery >Europe changes its medical guidelines based on this research >turns out beta blockers increase risk of

Delighted to share the final version of Richard Zhou's study on how the CD163 scavenger receptor cleans up after toxic haemoglobin spills out from our blood cells. An amazing grabber mechanism! rdcu.be/ewPA2

This team 😂😂

For the second year in a row, Parafilm has been recognized with the Nobel Prize in Chemistry 2025! 🏅